WHO世界卫生组织：2024年日内瓦高效和实用结核病治疗试验平台：会议报告（英文版）

Tuberculosis (TB) affects 10 million people annually and accounts for a 10% mortality rate despite available treatments. Challenges such as treatment complexity, adherence difficulties, and disease recurrence highlight the need for robust, real-world evidence to optimize therapies. The World Health Organization (WHO) proposes developing a collaborative trial platform, bringing together countries with high TB burdens to conduct large-scale, person-centred, pragmatic trials. This initiative aim